A detailed history of Warwick Investment Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Warwick Investment Management, Inc. holds 547 shares of LLY stock, worth $440,958. This represents 0.12% of its overall portfolio holdings.

Number of Shares
547
Previous 539 1.48%
Holding current value
$440,958
Previous $487,000 0.62%
% of portfolio
0.12%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $6,177 - $7,680
8 Added 1.48%
547 $484,000
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $54,365 - $68,178
75 Added 16.16%
539 $487,000
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $274,780 - $367,617
464 New
464 $360,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Warwick Investment Management, Inc. Portfolio

Follow Warwick Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warwick Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Warwick Investment Management, Inc. with notifications on news.